J
Jeanette Y. Lee
Researcher at University of Alabama at Birmingham
Publications - 7
Citations - 1569
Jeanette Y. Lee is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Multicenter trial & Viremia. The author has an hindex of 6, co-authored 7 publications receiving 1547 citations. Previous affiliations of Jeanette Y. Lee include National Institutes of Health & Santa Clara Valley Medical Center.
Papers
More filters
Journal ArticleDOI
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
Thomas J. Walsh,Peter G. Pappas,Drew J. Winston,Hillard M. Lazarus,Finn Bo Petersen,John Raffalli,Saul Yanovich,Patrick J. Stiff,Richard N. Greenberg,Gerald R. Donowitz,Mindy G. Schuster,Annette C. Reboli,John R. Wingard,Carola A.S. Arndt,John F. Reinhardt,Susan Hadley,Robert W. Finberg,Michel Laverdière,John R. Perfect,Gary Garber,Giuseppe Fioritoni,Eli Anaissie,Jeanette Y. Lee +22 more
TL;DR: Voriconazole is a suitable alternative to amphotericin B preparations for empirical antifungal therapy in patients with neutropenia and persistent fever in a randomized, international, multicenter trial.
Journal ArticleDOI
NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis
David W. Denning,David W. Denning,Jeanette Y. Lee,Jeanette Y. Lee,John S. Hostetler,John S. Hostetler,Peter G. Pappas,Peter G. Pappas,Carol A. Kauffman,Carol A. Kauffman,Daniel H. Dewsnup,Daniel H. Dewsnup,John N. Galgiani,John N. Galgiani,John R. Graybill,John R. Graybill,Alan M. Sugar,Alan M. Sugar,Antonino Catanzaro,Antonino Catanzaro,Harry A. Gallis,Harry A. Gallis,John R. Perfect,John R. Perfect,Bonita Dockery,Bonita Dockery,William E. Dismukes,William E. Dismukes,David A. Stevens,David A. Stevens +29 more
TL;DR: Oral itraconazole is a useful alternative therapy for invasive aspergillosis with response rates apparently comparable to amphotericin B, and relapse rates among those who completed therapy and those who discontinued early for possible toxicity were 12% and 40%, respectively.
Journal ArticleDOI
Sucralfate for radiation mucositis: Results of a double-blind randomized trial☆
Ruby F. Meredith,Merle Salter,Robert Y. Kim,Sharon A. Spencer,Burkhard Weppelmann,Brad Rodu,Judy Smith,Jeanette Y. Lee +7 more
TL;DR: A trend (that was not statistically significant) of less severe radiation mucositis was noted for patients receiving sucralfate in addition to the combination of viscous lidocaine, diphenhydramine, and antacid for nonulcerative radiation mucposis.
Journal ArticleDOI
Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy.
Cathal E. O'Sullivan,W. Lawrence Drew,Dragana J. McMullen,R C Miner,Jeanette Y. Lee,Richard A. Kaslow,James G. Lazar,Michael S. Saag +7 more
TL;DR: Immune reconstitution secondary to HAART results in a significant and progressive decline in CMV viremia in the absence of specific anti-CMV therapy.
Journal ArticleDOI
Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Michael S. Saag,W. Jeffrey Fessel,Carol A. Kaufman,Katherine W. Merrill,Douglas J. Ward,Bruce L. Moskovitz,Carolynn J. Thomas,Napoleon Oleka,Joseph Guarnieri,Jeanette Y. Lee,Leona Brenner-Gati,Mark Klausner +11 more
TL;DR: Itraconazole oral solution is demonstrated to be a useful therapy in the treatment of HIV-infected patients with fluconazole-refractory oropharyngeal candidiasis, and adverse events were predominantly gastrointestinal disturbances.